An integrated action plan is needed to overcome the diabetic pandemic

Diabetes is one of the four major types of noncommunicable diseases (NCDs) that enormously contribute to morbidity and mortality worldwide. In 2019, the International Diabetes Federation estimated 7.1 million people were living with Diabetes in Bangladesh and projected to be almost doubled by 2025. Considering this growing rate of Diabetic patients in the country, Sanofi Bangladesh, a subsidiary of Beximco Pharmaceuticals Limited, organised a scientific seminar on 'Diabetes in Bangladesh: Current Situation and Future Direction'.

On the occasion of World Diabetes Day 2021, Sanofi Bangladesh took the initiative to felicitate top young researchers in Diabetes. This platform recognised young researchers for their hard work and diligence and encourages aspiring researchers to work more and more in the challenging field of diabetes.

In the scientific seminar, the chairperson of the event, Professor Md Faruque Pathan, said, "Bangladesh is ranked as the 10th most Diabetic prone country globally, and the real scenario is graver than this. If we do not act now, the situation will go beyond control. Therefore, an integrated action plan and easy availability of all Diabetic care, including affordable medication is required to overcome the situation."